← Back to Search

Other

Blood flow restriction and standard of care therapy for Patellofemoral Pain Syndrome

N/A
Waitlist Available
Led By Eric Sokolowski
Research Sponsored by Gaylord Hospital, Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up this assessment will be collected 12 months post start date.
Awards & highlights

Study Summary

This trial will study if a therapy can help improve outcomes for people with knee pain.

Eligible Conditions
  • Patellofemoral Pain Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~this assessment will be collected 12 months post start date.
This trial's timeline: 3 weeks for screening, Varies for treatment, and this assessment will be collected 12 months post start date. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Harm Reduction
Harm Reduction
Harm Reduction
+30 more
Secondary outcome measures
Quadricep Isometric Strength: 1 Week
Quadricep Isometric Strength: 4 Weeks
Quadricep Isometric Strength: 9 Weeks/Discharge
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Blood flow restriction and standard of care therapyExperimental Treatment1 Intervention
The experimental BFR therapy will be incorporated into the standard therapy sessions and will not elongate the treatment session, quantity of sessions or incur any additional cost. As the participant progresses over time in therapy sessions, the discretion of the PT will determine when they have graduated beyond receiving any benefit from BFRT as demonstrated by quad strength.
Group II: Sham and standard of care therapyPlacebo Group1 Intervention
The sham comparator control group will also follow the Exercise Protocol in their physical therapy sessions with a non inflated blood flow restriction cuff attached in the same position as the experimental group. Similar to the intervention group, as participant's progress in therapy, the Physical Therapist will use their clinical decision making to advance the person through resistance and repetition increases.

Find a Location

Who is running the clinical trial?

Gaylord Hospital, IncLead Sponsor
6 Previous Clinical Trials
405 Total Patients Enrolled
UConn HealthOTHER
211 Previous Clinical Trials
60,620 Total Patients Enrolled
Eric SokolowskiPrincipal InvestigatorPhysical Therapist

Media Library

Blood Flow Restriction Cuff (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05617911 — N/A
Patellofemoral Pain Syndrome Research Study Groups: Sham and standard of care therapy, Blood flow restriction and standard of care therapy
Patellofemoral Pain Syndrome Clinical Trial 2023: Blood Flow Restriction Cuff Highlights & Side Effects. Trial Name: NCT05617911 — N/A
Blood Flow Restriction Cuff (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05617911 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many health centers are currently conducting this trial?

"This clinical trial is being conducted at 5 sites: Gaylord Specialty Healthcare Outpatient Physical Therapy; Cheshire, Gaylord Specialty Healthcare Outpatient Physical Therapy; Cromwell, University of Connecticut Health Center in Farmington and 2 additional medical facilities."

Answered by AI

Are there still opportunities to become involved in this research endeavor?

"As recently recorded on clinicaltrials.gov, this research initiative is still actively seeking participants for their trial. It was initially posted in November 15th 2022 and the latest update to the study occurred that same day."

Answered by AI

What is the uppermost limit of individuals participating in this trial?

"Affirmative, the clinical trial is still open for enrollment. It was initially posted on November 15th 2022 and has since been updated to its current version. 96 individuals are being sought from five distinct sites."

Answered by AI

What are the primary objectives of this research endeavor?

"This trial's primary outcome is to measure the Numeric Pain Rating Scale at 12 months post-enrollment. Secondary measurements will include Quadricep Isometric Strength tested 9 weeks after enrollment, 1 week into treatment and 4 weeks following it using an isometry dynamometer."

Answered by AI
~0 spots leftby Mar 2025